Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Acute Lymphoblastic Leukaemia

Matched-pair analysis comparing allogeneic PBPCT and BMT from HLA-identical relatives in childhood acute lymphoblastic leukemia

Bone Marrow Transplantation volume 30, pages 9–13 (2002)Cite this article

Abstract

This multicenter study was designed to evaluate whether allo-PBPCT provides some advantages, if any, over BMT in terms of engraftment kinetics, acute and chronic GVHD incidence, TRM, relapse incidence and survival in acute lymphoblastic leukemia patients (ALL). From January 1995 to December 1999, 67 ALL patients (34 in the PBPCT group and 33 in the BMT group) were included in this study. Median age for both groups was 8 years (range, 1–18). There were 24 patients in first or second CR in the PBPCT group and 28 such patients in the BMT group. Preparatory regimens were TBI-based in 26/34 in the PBPC group and 25/33 in the BMT group. GVHD prophylaxis was CsA alone in 38 patients (18 PBPCT vs 20 BMT) and CsA plus short Mtx in 29 (16 PBPCT vs 13 BMT). Engraftment was achieved in all cases. Median days to neutrophil recovery was 10 (range, 7–18) after PBPCT vs 14 (range, 9–21) after BMT (P < 0.0001). platelet engraftment (>50 × 109/l) was also faster for PBPCT patients (median 13 days, range, 9–40 vs 23 days, range, 15–165) (P < 0.0001). Acute GVHD grade II–IV incidence was similar in both groups (46.4 ± 8.8% vs 42.7 ± 8.6%) (P = 0.45). Probability of chronic GVHD was 50.6 ± 12.2% after PBPCT vs 27.8 ± 9.2% after BMT (P = 0.1). Probability of relapse was similar (28.7 ± 9.2% for PBPCT vs 27.1 ± 8.2% for BMT) (P = 0.89). There were eight patients who died from transplant-related complications after PBPCT vs 5 after BMT (P, NS). With a median follow-up of 25 months the event-free survival probability was 53 ± 8.9% for PBPCT vs 54.9 ± 9.7% for BMT (P = 0.54). Using PBPC for allogeneic transplantation in childhood ALL results in faster hematopoietic recovery compared to BM, with a similar incidence of aGVHD, TRM, relapse and disease-free survival. However, the issue of cGVHD remains unresolved.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Brochstein JA, Kernan N, Groshen S et al. Allogeneic bone marrow transplantation after hyperfractionated total body irradiation and cyclophosphamide in children with acute leukemia New Engl J Med 1987 317: 1618 1624

    Article  CAS  PubMed  Google Scholar 

  2. Dopfer R, Henze G, Bender-Gotze C et al. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: Results of the German Cooperative study Blood 1991 78: 2780 2784

    CAS  PubMed  Google Scholar 

  3. Barrett AJ, Horowitz MM, Pollock BH et al. Bone marrow transplantation from HLA-identical siblings as compared with chemo-therapy for children with acute lymphoblastic leukemia in a second remission New Engl J Med 1994 331: 1253 1258

    Article  CAS  PubMed  Google Scholar 

  4. Wheeler K, Richards S, Bailey C, Chessels J . Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience Br J Haematol 1998 101: 94 103

    Article  CAS  PubMed  Google Scholar 

  5. Bordigoni P, Esperou H, Souillet G et al. Total body irradiation, high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukemia after relapse while receiving chemotherapy: a Société Française de Greffe de Moelle study Br J Haematol 1998 102: 656 665

    Article  CAS  PubMed  Google Scholar 

  6. Boulad F, Steinherz P, Reyes B et al. Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission: a single-institution study J Clin Oncol 1999 17: 197 207

    Article  CAS  PubMed  Google Scholar 

  7. Ringden O, Bolme P, Lonnqvist B et al. Allogeneic bone marrow transplantation versus chemotherapy in children with acute leukemia in Sweden Pediatr Hematol Oncol 1989 6: 137 144

    Article  CAS  PubMed  Google Scholar 

  8. Bensinger WI, Weaver CH, Appelbaum FR et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor Blood 1995 85: 1655 1658

    CAS  PubMed  Google Scholar 

  9. Körbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood versus marrow allografts Blood 1995 85: 1659 1665

    PubMed  Google Scholar 

  10. Schmitz N, Dreger P, Suttorp M et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) Blood 1995 85: 1666 1672

    CAS  PubMed  Google Scholar 

  11. Bensinger WI, Clift R, Martin P et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation Blood 1996 88: 2794 2800

    CAS  PubMed  Google Scholar 

  12. Przepiorka D, Anderlini P, Ippoliti C et al. Allogeneic blood stem cell transplantation in advanced hematologic cancers Bone Marrow Transplant 1997 19: 455 460

    Article  CAS  PubMed  Google Scholar 

  13. Schmitz N, Bacigalupo A, Labopin M et al. Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors Br J Haematol 1996 95: 715 723

    Article  CAS  PubMed  Google Scholar 

  14. Korbling M, Chan KW, Anderlini P et al. Allogeneic peripheral blood stem cell transplantation using normal patient-related pediatric donors Bone Marrow Transplant 1996 18: 885 890

    CAS  PubMed  Google Scholar 

  15. Li CK, Yuen PM, Chik KW et al. Allogeneic peripheral blood stem cell transplant in children Med Pediatr Oncol 1998 30: 147 151

    Article  CAS  PubMed  Google Scholar 

  16. Villa M, Madero L, Diaz MA et al. Allogeneic peripheral blood progenitor cell (PBPC) transplantation in children Bone Marrow Transplant 1996 18: 231 233

    CAS  PubMed  Google Scholar 

  17. Diaz MA, Alegre A, Villa M et al. Allogeneic peripheral blood progenitor cell (PBPC) transplantation in children with haematological malignancies Br J Haematol 1997 96: 161 164

    Article  CAS  PubMed  Google Scholar 

  18. De la Rubia J, Martínez C, Solano C et al. Administration of recombinant human granulocyte colony-stimulating factor to normal donors: results of the Spanish National Donor Registry. Spanish Group of Allo-PBT Bone Marrow Transplant 1999 24: 723 728

    Article  CAS  PubMed  Google Scholar 

  19. Gonzalez M, Benito A, Dìaz MA, Madero L . Peripheral blood progenitor cell (PBPC) collection by large-volume leukapheresis from pediatric donors Bone Marrow Transplant 1999 23: 631 632

    Article  CAS  PubMed  Google Scholar 

  20. De la Rubia J, Diaz MA, Verdeguer A et al. Donor age-related differences in PBPC mobilization with rHuG-CSF Transfusion 2001 41: 201 205

    Article  CAS  PubMed  Google Scholar 

  21. Przepiorka D, Weisdorf D, Martin P et al. 1994 Consensus conference on acute GVHD grading Bone Marrow Transplant 1995 15: 825 828

    CAS  PubMed  Google Scholar 

  22. Atkinson K, Horowitz MM, Gale RP et al. Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease. Committee of the International Bone Marrow Transplant Registry Bone Marrow Transplant 1989 4: 247 254

    CAS  PubMed  Google Scholar 

  23. Kaplan EL, Meier P . Nonparametric estimation from incomplete, observations J Am Stat Assoc 1958 53: 457 481

    Article  Google Scholar 

  24. Singhal S, Powles R, Kulkarni S et al. Comparison of marrow and blood cell yields from the same donor in a double-blind, randomized study of allogeneic marrow versus blood stem cell transplantation Bone Marrow Transplant 2000 25: 501 505

    Article  CAS  PubMed  Google Scholar 

  25. Powles R, Mehta J, Kulkarni S et al. Allogeneic blood and bone marrow stem-cell transplantation in haematological malignant diseases: a randomised trial Lancet 2000 355: 1231 1237

    Article  CAS  PubMed  Google Scholar 

  26. Bensinger WI, Martin PJ, Storer B et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers New Engl J Med 2001 344: 175 181

    Article  CAS  PubMed  Google Scholar 

  27. Lickliter JD, McGlave PB, DeFor TE et al. Matched-pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation Bone Marrow Transplant 2000 26: 723 728

    Article  CAS  PubMed  Google Scholar 

  28. Vigorito AC, Azevedo WM, Marques JF et al. A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies Bone Marrow Transplant 1998 22: 1145 1151

    Article  CAS  PubMed  Google Scholar 

  29. Schmitz N, Bacigalupo A, Hasenclever D et al. Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation Bone Marrow Transplant 1998 21: 995 1003

    Article  CAS  PubMed  Google Scholar 

  30. Blaise D, Kuentz M, Fortanier C et al. Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle J Clin Oncol 2000 18: 537 546

    Article  CAS  PubMed  Google Scholar 

  31. Mielcarek M, Martin PJ, Torok-Storb B . Suppression of alloantigen-induced T-cell proliferation by CD141 cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells Blood 1997 89: 1629 1634

    CAS  PubMed  Google Scholar 

  32. Pan L, Delmonte J Jr, Jalonen CK, Ferrara JLM . Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease Blood 1995 86: 4422 4429

    CAS  PubMed  Google Scholar 

  33. Talmadge JE, Reed EC, Kessinger A et al. Immunologic attributes of cytokine mobilized peripheral blood stem cells and recovery following transplantation Bone Marrow Transplant 1996 17: 101 109

    CAS  PubMed  Google Scholar 

  34. Kawano Y, Watanabe T, Takaue Y et al. Mobilization/harvest and transplantation with blood stem cells, manipulated or unmanipulated Pediatr Transplantation 1999 3: (Suppl. 1) 65 71

    Article  Google Scholar 

  35. Watanabe T, Kajiume T, Abe T et al. Allogeneic peripheral blood stem cell transplantation in children with hematological malignancies from HLA-matched siblings Med Ped Oncol 2000 34: 171 176

    Article  CAS  Google Scholar 

  36. Levine JE, Willey J, Kletzel M et al. Cytokine-mobilized allogeneic peripheral blood stem cell transplants in children result in rapid engraftment and a high incidence of chronic GVHD Bone Marrow Transplant 2000 25: 13 18

    Article  CAS  PubMed  Google Scholar 

  37. Madero L, Gonzalez Vicent M, Ramirez M et al. Clinical and economic comparison of allogeneic peripheral blood progenitor cell and bone marrow transplantation for acute lymphoblastic leukemia in children Bone Marrow Transplant 2000 26: 269 273

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hospital Niño Jesus, Madrid, Spain

    MG Vicent, L Madero & MA Diaz

  2. Hospital Valle Hebron, Barcelona, Spain

    JJ Ortega & T Olive

  3. Hospital La Paz, Madrid, Spain

    A Martinez

  4. Hospital Reina Sofia, Cordoba, Spain

    P Gomez

  5. Hospital La Fe, Valencia, Spain

    A Verdeguer & E Bureo

  6. Hospital Santa Cruz y San Pablo, Barcelona, Spain

    I Badell & J Cubells

  7. Hospital Ramon y Cajal, Madrid, Spain

    A Muñoz & MS Maldonado

Authors
  1. MG Vicent
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L Madero
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. JJ Ortega
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A Martinez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P Gomez
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A Verdeguer
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. I Badell
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A Muñoz
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. T Olive
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. MS Maldonado
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. E Bureo
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. J Cubells
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. MA Diaz
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

on behalf of Spanish Working Party for BMT in Children (GETMON)

Additional information

Hospital Marques de Valdecilla, Santander, Spain.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vicent, M., Madero, L., Ortega, J. et al. Matched-pair analysis comparing allogeneic PBPCT and BMT from HLA-identical relatives in childhood acute lymphoblastic leukemia. Bone Marrow Transplant 30, 9–13 (2002). https://doi.org/10.1038/sj.bmt.1703589

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703589

Keywords

This article is cited by

Search

Advanced search

Quick links